{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:48:04Z","timestamp":1788281284973,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:p>\n                    This study aimed to determine whether specific diagnostic cutoff thresholds of serum reproductive hormones \u2013 anti-M\u00fcllerian hormone (AMH), estradiol (E\n                    <jats:sub>2<\/jats:sub>\n                    ), and follicle-stimulating hormone (FSH) \u2013 can function as cost-effective triage tools for identifying postmenopausal women at high risk of osteoporosis in settings with limited access to dual-energy X-ray absorptiometry (DXA). This prospective cross-sectional study was conducted at the Department of Obstetrics and Gynecology, Harran University Faculty of Medicine, between April and October 2025. A total of 312 postmenopausal women were enrolled. Bone mineral density (BMD) was assessed using DXA and categorized as normal, osteopenia, or osteoporosis according to World Health Organization criteria. Serum AMH, E\n                    <jats:sub>2<\/jats:sub>\n                    , and FSH concentrations were measured using an electrochemiluminescence immunoassay. Logistic regression and receiver operating characteristic analyses were performed to identify independent predictors and determine optimal hormonal thresholds for the diagnosis of osteoporosis. Of 312 participants, 84 (26.9%) had normal BMD, 139 (44.6%) had osteopenia, and 89 (28.5%) had osteoporosis. As BMD declined, AMH and E\n                    <jats:sub>2<\/jats:sub>\n                    levels decreased, while FSH increased significantly (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Logistic regression identified low AMH (odds ratio [OR]\u2005=\u20050.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001), low E\n                    <jats:sub>2<\/jats:sub>\n                    (OR\u2005=\u20050.89,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and high FSH (OR\u2005=\u20051.02,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.042) as independent predictors of osteoporosis based on femoral neck BMD. Receiver operating characteristic analysis demonstrated excellent discriminative performance for AMH (area under the curve [AUC]\u2005=\u20050.83 for femoral neck; 0.81 for lumbar spine) and E\n                    <jats:sub>2<\/jats:sub>\n                    (AUC\u2005=\u20050.82 for femoral neck; 0.80 for lumbar spine), both outperforming FSH (AUC\u2005=\u20050.72 and 0.71, respectively). Optimal Youden thresholds were \u22640.01\u2009ng\/mL for AMH and \u226421 pg\/mL for E\n                    <jats:sub>2<\/jats:sub>\n                    , each achieving strong positive predictive values of approximately 90%. AMH\u2005\u2264\u20050.02\u2009ng\/mL yielded 90.8% sensitivity, suggesting potential utility as a screening marker. E\n                    <jats:sub>2<\/jats:sub>\n                    and AMH demonstrated superior diagnostic performance across both femoral and lumbar sites, with optimal cutoffs (AMH\u2005\u2264\u20050.01\u2009ng\/mL; E\n                    <jats:sub>2<\/jats:sub>\n                    \u2005\u2264\u200521 pg\/mL) achieving positive predictive values near 90%. This strongly supports their utility as accessible, biologically grounded triage tools for prioritizing high-risk women for DXA scanning in resource-constrained settings.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048162","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:00:54Z","timestamp":1774630854000},"page":"e48162","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Repurposing reproductive hormones as a cost-effective triage tool for osteoporosis in resource-limited settings: A prospective study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-441X","authenticated-orcid":false,"given":"Mehmet","family":"\u0130ncebiyik","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Research and Application Hospital, Harran University Faculty of Medicine, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe G\u00fcl","family":"Hilali","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Harran University Faculty of Medicine, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Er","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Mehmet Akif \u0130nan Training and Research Hospital, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Tammo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Harran University Faculty of Medicine, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Ziya","family":"Kizildemir","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Harran University Faculty of Medicine, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahime","family":"Kada D\u00fcken","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mehmet Akif \u0130nan Training and Research Hospital, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Kalir","sequence":"additional","affiliation":[{"name":"Department of Nursing, Harran University, \u015eanliurfa, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Erdal","family":"Sak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Harran University Faculty of Medicine, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260506","first-page":"286","article-title":"Postmenopausal women and osteoporosis.","volume":"3","author":"Garg","year":"2020","journal-title":"Invest Gynecol Res Womens Health"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis.","volume":"4","author":"S\u00f6zen","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697137.2021.1951206","article-title":"Osteoporosis and fractures in women: the burden of disease.","volume":"25","author":"Lorentzon","year":"2021","journal-title":"Climacteric"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","article-title":"DXA parameters, Trabecular Bone Score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis.","volume":"74","author":"Shevroja","year":"2021","journal-title":"Endocrine"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18110","article-title":"Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.","volume":"18","author":"Burch","year":"2014","journal-title":"Health Technol Assess"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/ijms23031376","article-title":"Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover.","volume":"23","author":"Cheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"e0134986","DOI":"10.1371\/journal.pone.0134986","article-title":"Follicle-stimulating hormone increases the risk of postmenopausal osteoporosis by stimulating osteoclast differentiation.","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-024-01220-5","article-title":"Genetic prediction of osteoporosis by anti-M\u00fcllerian hormone levels and reproductive factors in women: a Mendelian randomization study.","volume":"115","author":"Li","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.7150\/ijms.26571","article-title":"The relationship between follicle-stimulating hormone and bone health: alternative explanation for bone loss beyond oestrogen?","volume":"15","author":"Chin","year":"2018","journal-title":"Int J Med Sci"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2010.11.011","article-title":"Follicle-stimulating hormone promotes RANK expression on human monocytes.","volume":"53","author":"Cannon","year":"2011","journal-title":"Cytokine"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","article-title":"FSH directly regulates bone mass.","volume":"125","author":"Sun","year":"2006","journal-title":"Cell"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12020-025-04265-0","article-title":"The role of anti-M\u00fcllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction.","volume":"89","author":"Karaviti","year":"2025","journal-title":"Endocrine"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jbmr.4525","article-title":"Anti\u2010Mullerian hormone as predictor of future and ongoing bone loss during the menopause transition.","volume":"37","author":"Karlamangla","year":"2022","journal-title":"J Bone Miner Res"},{"key":"R14-20260506","article-title":"Dietary reference intakes for calcium and vitamin D.","author":"Ross","year":"2011","journal-title":"National Academies Press"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2018-00005","article-title":"Pituitary diseases and bone.","volume":"39","author":"Mazziotti","year":"2018","journal-title":"Endocr Rev"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/1354750X.2020.1833083","article-title":"Serum anti-M\u00fcllerian hormone levels are associated with low bone mineral density in premenopausal women.","volume":"25","author":"Yan","year":"2020","journal-title":"Biomarkers"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/s41598-025-89985-z","article-title":"The association between sex hormones and bone mineral density in US females.","volume":"15","author":"Tian","year":"2025","journal-title":"Sci Rep"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review.","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum Reprod Update"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"223","DOI":"10.11005\/jbm.2021.28.3.223","article-title":"Anti-M\u00fcllerian hormone negatively regulates osteoclast differentiation by suppressing the receptor activator of nuclear factor-\u03baB ligand pathway.","volume":"28","author":"Kim","year":"2021","journal-title":"J Bone Metabol"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.","volume":"17","author":"Heshmati","year":"2002","journal-title":"J Bone Miner Res"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/jbmr.3856","article-title":"Estradiol and follicle\u2010stimulating hormone as predictors of onset of menopause transition\u2010related bone loss in pre\u2010 and perimenopausal women.","volume":"34","author":"Shieh","year":"2019","journal-title":"J Bone Miner Res"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/geriatrics8030057","article-title":"Antim\u00fcllerian hormone as a tool to predict the age at menopause.","volume":"8","author":"Chatziandreou","year":"2023","journal-title":"Geriatrics (Basel)"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13020-022-00622-7","article-title":"Serum biomarker-based osteoporosis risk prediction and the systemic effects of Trifolium pratense ethanolic extract in a postmenopausal model.","volume":"17","author":"Quah","year":"2022","journal-title":"Chin Med"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.5455\/annalsmedres.2022.07.200","article-title":"The relation of anti-Mullerian hormone with final menstrual period and menopausal symptoms in the menopausal transition.","volume":"29","author":"Erturk","year":"2022","journal-title":"Ann Med Res"},{"key":"R26-20260506","first-page":"1","article-title":"Correlation of serum anti-Mullerian hormone and inhibin-B levels with osteoporosis of menopausal woman in Chinese Daur ethnic group.","volume":"32","author":"Zhao","year":"2024","journal-title":"J Orthop Surg"},{"key":"R27-20260506","doi-asserted-by":"crossref","first-page":"585604","DOI":"10.1155\/2015\/585604","article-title":"Comparison of specificity and sensitivity of AMH and FSH in diagnosis of premature ovarian failure.","volume":"2015","author":"Alipour","year":"2015","journal-title":"Dis Markers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:00:40Z","timestamp":1778076040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048162","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"2025-12-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}